First real-world data for rVSV-ZEBOV vaccine supports use for future Ebola outbreaks

First real-world data for rVSV-ZEBOV vaccine supports use for future Ebola outbreaks

Submitted by admin on August 27, 2024 - 11:38am
Source: 
Clinical Trials Arena
News Tags: 
Merck
vaccines
rVSV-ZEBOV
ebola virus
real world data
Headline: 
First real-world data for rVSV-ZEBOV vaccine supports use for future Ebola outbreaks
snippet: 

A recent study has revealed that the first real-world effectiveness estimates of the rVSV-ZEBOV vaccine against Ebola were approximately 84%.

Do Not Allow Advertisers to Use My Personal information